SMN2 and proximal spinal muscular atrophy: Spinal muscular atrophy represents an incredibly suitable target for the use of ASOs because of the presence of the defective SMN2 rescue gene, the duality of both weak 3′ and 5′ exon 7 splice-sites and the presence of many local and regional splicing silencers and enhancers.